Public-registry site landscape for NCT04260126, a Metastatic Head and Neck Cancer study sponsored by PDS Biotechnology Corp.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04260126 (registry record) |
| Sponsor | PDS Biotechnology Corp. |
| Condition(s) | Metastatic Head and Neck Cancer; Recurrent Head and Neck Cancer; HPV Positive Oropharyngeal Squamous Cell Carcinoma; Neoplasms, Head and Neck |
| Phase | PHASE2 |
| Listed sites | 23 |
| Site countries | United States, Ireland, Puerto Rico, United Kingdom |
Eichor generates a preliminary site-risk snapshot for NCT04260126 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →